Maya AlQawasmi

Dr. Maya AlQawasmi

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2026 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
MSMontserrat Villa Sanchez
Montserrat Villa Sanchez
RRRuth Alejandra Diaz Revelo
Ruth Alejandra Diaz Revelo
MAMaya AlQawasmi
Maya AlQawasmi
AHAlaa Hamrouni
Alaa Hamrouni
NDNowis Duerto
Nowis Duerto
EMErnesto Calderon Martinez
Ernesto Calderon Martinez
Background: Endovascular revascularization is a cornerstone therapy for peripheral artery disease (PAD), typically guided by angiography, which may underestimate vessel size and lesion complexity. The clinical benefit of intravascular ultrasound (IVUS) guidance remains uncertain. This systemic review and meta-analysis compare clinical outcomes of IVUS-guided versus angiography-guided endovascular interventions in patients with PAD. Methods: PubMed/MEDLINE, Cochrane, Scopus, Web of Science, EMBASE, and Google Scholar were searched from inception through January 30, 2026, for randomized and observational studies of adults with PAD undergoing endovascular interventions with IVUS versus angiography. Primary outcomes were primary patency, target lesion revascularization (TLR), and late lumen loss. Secondary outcomes included major adverse limb events, amputation, procedural success, and ankle–brachial index improvement. Random-effects meta-analysis was performed using R version 3.4.3. Results: Twenty-three studies encompassing 1,232,018 patients were included. There was no significant difference between IVUS-guided and angiography-guided interventions (RR 1.03; 95% CI 0.81–1.23; p = 0.75; i2 = 60.3%) or freedom from TLR (RR 1.21; 95% CI 0.96–1.54; p = 0.08; I2 = 58.6%). Conclusion: IVUS-guided endovascular interventions in PAD were associated with reduced all-cause mortality, but similar limb-related outcomes compared with angiography guidance. However, these findings are based predominantly on observational evidence. Large-scale randomized trials are needed to confirm these findings and identify patient subgroups that would benefit from IVUS-guided strategies.